LINTHICUM, Md., Jan. 5 Dialysis Corporation ofAmerica (Nasdaq: DCAI) announced the acquisition of a dialysis center inHyattsville, Maryland, located at the St. Thomas More Nursing andRehabilitation Center, where it can treat patients from both within the St.Thomas More Center, as well as the surrounding community.
This new center has 24 treatment stations and is currently caring forapproximately 145 dialysis patients. The company is considering adding sixmore stations to the facility, which will accommodate up to an additional 36patients.
President & CEO Stephen Everett commented "This newest center in Marylandis strategic to DCA as we begin 2009. It marks our fourth facility located onthe campus of a skilled nursing facility, and our sixth in Maryland, whichremains a focused market for DCA. Additionally, we are very fortunate to beinheriting a great group of caregivers in a community with several excellentnephrologists."
Dialysis Corporation of America owns and operates freestanding kidneyhemodialysis centers located in Georgia, Maryland, New Jersey, Ohio,Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysisservices on a contract basis to certain hospitals located in the those states.The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis services.
This release contains forward-looking statements that are subject to risksand uncertainties that could affect the business and prospects of the companyand cause actual results and plans to differ materially from thoseanticipated. Those factors include, but are not limited to, increases ininterest rates, the possible need for and availability of additionalfinancing, the company's satisfying the covenants and conditions of its creditfacility, certain delays beyond the company's control with respect to futurebusiness events, the highly competitive environment in the establishment andoperation of dialysis centers, the ability to develop or acquire additionaldialysis facilities, whether patient bases of the company's dialysisfacilities can mature to provide profitability, the extensive regulation ofdialysis operations, government rate determination for Medicare reimbursement,pricing pressure from private payors, and other risks detailed in thecompany's filings with the SEC, particularly as described in the company'sannual report on Form 10-K for the fiscal year ended December 31, 2007. Thehistorical results contained in this press release are not necessarilyindicative of future performance of the company.
Other Dialysis Corporation of America press releases, corporate profile,corporate governance materials, quarterly and current reports, and otherfilings with the Securities and Exchange Commission are available on DialysisCorporation of America's internet home page:http://www.dialysiscorporation.com.
CONTACT: For additional information, you may contact Dialysis Corporationof America, 1302 Concourse Drive, Suite 204, Linthicum, MD 21090; TelephoneNumber (410) 694-0500; Attention: Investor Relations.
SOURCE Dialysis Corporation of America